Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7204980 Methods for inhibiting viral replication in vivo

Patent 7204980 was granted and assigned to PHOENIX PHARMACOLOGICS, INC. on April, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

PHOENIX PHARMACOLOGICS, INC.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

April 17, 2007

0

Patent Application Number

106746660

Date Filed

September 29, 2003

0

Patent Citations Received

US Patent 11691995 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications

0

Patent Primary Examiner

Bruce R. Campell

0

Patent abstract

The present invention is directed to methods of modulating viral replication in vivo comprising administering to an individual a therapeutically or prophylactically effective amount of a composition comprising arginine deiminase modified with polyethylene glycol, to methods of concurrently modulating viral replication and treating cancer, and to methods of modulating nitric oxide levels in a patient, among others.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7204980 Methods for inhibiting viral replication in vivo

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.